Cart (Loading....) | Create Account
Close category search window

Patents - universities feel the pain

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

1 Author(s)

This paper discusses the recent case of the University of Rochester vs. Searle that was presented at the Court of Appeals for the Federal Circuit. The case involved the patency of a new class of blockbuster drugs known as Cox-2 inhibitors, sold under such trademarks as Celebrex®, and Vioxx® which are used to lessen the pain of osteoarthritis and other inflammatory diseases. These drugs were known to work by inhibiting the ability of certain enzymes (cyclooxygenases) to produce a certain molecule (prostaglandin H2).

Published in:

Engineering in Medicine and Biology Magazine, IEEE  (Volume:23 ,  Issue: 3 )

Date of Publication:

May-June 2004

Need Help?

IEEE Advancing Technology for Humanity About IEEE Xplore | Contact | Help | Terms of Use | Nondiscrimination Policy | Site Map | Privacy & Opting Out of Cookies

A not-for-profit organization, IEEE is the world's largest professional association for the advancement of technology.
© Copyright 2014 IEEE - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.